| scholarly article | Q13442814 |
| P2093 | author name string | C P Tensen | |
| J Tekstra | |||
| C J De Groot | |||
| R H Beelen | |||
| P Van Der Valk | |||
| P Van Der Voorn | |||
| P2860 | cites work | Human chemokines: an update | Q28237635 |
| The pathological evolution of multiple sclerosis | Q35850662 | ||
| Chemokines and tissue injury | Q40543142 | ||
| Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma? | Q40689750 | ||
| The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. | Q40811194 | ||
| Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives | Q40895456 | ||
| Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats | Q41348774 | ||
| Basic mechanisms of brain inflammation. | Q41446753 | ||
| Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages | Q42017099 | ||
| Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis | Q48100149 | ||
| Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions | Q48126443 | ||
| Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions | Q48554897 | ||
| Monocyte/macrophage differentiation in early multiple sclerosis lesions | Q48752790 | ||
| Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions | Q48822577 | ||
| Macrophage inflammatory protein-1 alpha in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. | Q55240794 | ||
| A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells | Q56943526 | ||
| Chemokine expression in murine experimental allergic encephalomyelitis | Q58201535 | ||
| The intracellular signaling pathways involved in MCP-1-stimulated T cell migration across microvascular endothelium | Q71006183 | ||
| Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro | Q71217167 | ||
| Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody | Q72080088 | ||
| Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats | Q72556738 | ||
| Pathogenesis of multiple sclerosis | Q72665671 | ||
| Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes | Q73082091 | ||
| Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization | Q73480802 | ||
| Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9 | Q73979408 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| astrocyte | Q502961 | ||
| P304 | page(s) | 45-51 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions | |
| P478 | volume | 154 |
| Q35064496 | A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis |
| Q50657622 | A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS. |
| Q48223089 | A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis |
| Q37075106 | AMP-activated protein kinase restricts IFN-γ signaling. |
| Q28755978 | Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis |
| Q36894072 | Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients |
| Q103034460 | Altered astrocytic function in experimental neuroinflammation and multiple sclerosis |
| Q44304140 | Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cells |
| Q33252011 | An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians |
| Q44932111 | Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis |
| Q44729461 | Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells. |
| Q33425955 | Astrocyte- and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation |
| Q34076791 | Astrocytes express functional chemokine receptors |
| Q28282324 | Astrocytes in multiple sclerosis: a product of their environment |
| Q37858667 | Astrocytes in the tempest of multiple sclerosis. |
| Q48312558 | Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5. |
| Q36878427 | Astrocytes--friends or foes in multiple sclerosis? |
| Q26861132 | Astrocytes: the missing link in neurologic disease? |
| Q34720644 | Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis |
| Q36173387 | Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation |
| Q34243826 | CCL2 modulates cytokine production in cultured mouse astrocytes. |
| Q34154663 | CCL2-expressing astrocytes mediate the extravasation of T lymphocytes in the brain. Evidence from patients with glioma and experimental models in vivo |
| Q48332388 | CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and the dentate gyrus during and after pilocarpine-induced status epilepticus |
| Q40196566 | Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy |
| Q57846940 | Cerebrospinal Fluid Monocyte Chemoattractant Protein-1 in Alcoholics: Support for a Neuroinflammatory Model of Chronic Alcoholism |
| Q36082738 | Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain |
| Q44426802 | Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury |
| Q48883778 | Chemokine CCL2 up-regulated in the medullary dorsal horn astrocytes contributes to nocifensive behaviors induced by experimental tooth movement |
| Q83870435 | Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis |
| Q48215354 | Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. |
| Q34361372 | Chemokine targets in acute brain injury and disease. |
| Q34435582 | Chemokines and central nervous system disorders |
| Q48651342 | Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. |
| Q36734084 | Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies |
| Q35771258 | Chemokines and glial cells: a complex network in the central nervous system. |
| Q35196338 | Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. |
| Q34306643 | Chemokines and viral diseases of the central nervous system |
| Q37684327 | Chemokines, neuronal-glial interactions, and central processing of neuropathic pain |
| Q36357407 | Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy |
| Q46692808 | Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones |
| Q39381152 | Curcumin inhibits LPS-induced CCL2 expression via JNK pathway in C6 rat astrocytoma cells |
| Q33644063 | Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis |
| Q43489327 | Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli |
| Q47559126 | Deciphering sex differences in the immune system and depression. |
| Q42143711 | Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1. |
| Q41813939 | Differential regulation of CD4+ T cell adhesion to cerebral microvascular endothelium by the β-chemokines CCL2 and CCL3. |
| Q34151104 | Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients |
| Q41181881 | Effects of an Inhibitor of Monocyte Recruitment on Recovery from Traumatic Brain Injury in Mice Treated with Granulocyte Colony-Stimulating Factor. |
| Q77759487 | Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE |
| Q42229875 | Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation |
| Q33929484 | Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes |
| Q36955863 | Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. |
| Q53099338 | Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis. |
| Q35466511 | Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. |
| Q74016845 | Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue |
| Q38301622 | Fatty acid-binding protein 7 regulates function of caveolae in astrocytes through expression of caveolin-1. |
| Q24307605 | Functional expression of CCR2 by human fetal astrocytes |
| Q35592638 | Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis |
| Q57584461 | Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis |
| Q48955254 | Genetic expression profile of olfactory ensheathing cells is distinct from that of Schwann cells and astrocytes |
| Q39330225 | Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls |
| Q35330799 | Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis |
| Q34398626 | Glial cell influence on the human blood-brain barrier |
| Q33911142 | Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease? |
| Q24525274 | Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha |
| Q44851919 | Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte |
| Q38272285 | Immune responses to non-tumor antigens in the central nervous system. |
| Q36153387 | Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis |
| Q47776071 | Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. |
| Q39316343 | Increased IL-13 but not IL-5 production by CD4-positive T cells and CD8-positive T cells in multiple sclerosis during relapse phase |
| Q56795446 | Increased proinflammatory cytokine and chemokine responses and microglial infection following inoculation with neural stem cells infected with polytropic murine retroviruses |
| Q40598016 | Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa B. |
| Q26858882 | Innate immunity in the central nervous system |
| Q59389230 | Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis |
| Q37194288 | JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain |
| Q44024257 | Ligand up-regulation does not correlate with a role for CCR1 in pathogenesis in a mouse model of non-lymphocyte-mediated neurological disease |
| Q33761191 | Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues |
| Q44412466 | Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse. |
| Q35063750 | Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis |
| Q41874688 | MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS |
| Q73223366 | Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions |
| Q33243924 | Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis |
| Q35788126 | Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis |
| Q42968743 | Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis |
| Q48726201 | Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis |
| Q46030490 | Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis. |
| Q33753720 | Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy |
| Q33850754 | Molecular pathogenesis of multiple sclerosis |
| Q35208773 | Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis |
| Q24314285 | Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase |
| Q38965249 | Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer |
| Q28910423 | Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis |
| Q34236583 | N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis |
| Q92724043 | Nanomodulation of Macrophages in Multiple Sclerosis |
| Q36824063 | Neuroimmune communication in hypertension and obesity: a new therapeutic angle? |
| Q34612473 | Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism |
| Q38610689 | Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research |
| Q35688300 | Novel Therapeutic Targets in Neuroinflammation and Neuropathic Pain |
| Q64121986 | Nox2-dependent Neuroinflammation in An EAE Model of Multiple Sclerosis |
| Q37174777 | On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter? |
| Q38636839 | Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation |
| Q36639036 | Pain in experimental autoimmune encephalitis: a comparative study between different mouse models |
| Q38246264 | Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines? |
| Q52548644 | Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. |
| Q45740367 | Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. |
| Q42420170 | Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation |
| Q37356125 | Possible role of glial cells in the onset and progression of Lyme neuroborreliosis |
| Q39385980 | Properties of 7ND-CCL2 are modulated upon fusion to Fc. |
| Q37347220 | Proteomic strategies in multiple sclerosis and its animal models |
| Q28577986 | Reciprocal regulation of ATPgammaS-induced monocyte chemoattractant protein-1 production by ERK and p38 MAP kinases in rat corticostriatal slice cultures |
| Q42465251 | Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. |
| Q43173412 | Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. |
| Q42514926 | Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. |
| Q36039356 | Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway |
| Q36368947 | Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. |
| Q34170906 | Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks |
| Q26996314 | Roles and functions of HIV-1 Tat protein in the CNS: an overview |
| Q77359980 | Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis |
| Q27335272 | Systemic simvastatin rescues retinal ganglion cells from optic nerve injury possibly through suppression of astroglial NF-κB activation |
| Q37794396 | Targeting astrocyte signaling for chronic pain |
| Q34181442 | The C Terminus of Mouse Monocyte Chemoattractant Protein 1 (MCP1) Mediates MCP1 Dimerization while Blocking Its Chemotactic Potency |
| Q44542754 | The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons |
| Q43805345 | The chemokine receptor CCR2 mediates the binding and internalization of monocyte chemoattractant protein-1 along brain microvessels. |
| Q92213495 | The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q28577554 | The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s) |
| Q48484747 | The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions |
| Q35031901 | The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). |
| Q36736188 | The target tissue in autoimmunity--an influential niche |
| Q36181285 | The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain. |
| Q39038441 | The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain |
| Q26999030 | Therapeutic targets in the ASK1-dependent stress signaling pathways |
| Q35682561 | Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. |
| Q74413491 | Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats |
| Q33788907 | Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus |
| Q37397206 | Yin and Yang of PDGF-mediated signaling pathway in the context of HIV infection and drug abuse |
| Q79151474 | [Chemokine--possible new options for the treatment of multiple sclerosis] |
Search more.